Olaf Schultz

1.4k total citations
25 papers, 1.1k citations indexed

About

Olaf Schultz is a scholar working on Rheumatology, Surgery and Urology. According to data from OpenAlex, Olaf Schultz has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 11 papers in Surgery and 8 papers in Urology. Recurrent topics in Olaf Schultz's work include Osteoarthritis Treatment and Mechanisms (11 papers), Periodontal Regeneration and Treatments (8 papers) and Knee injuries and reconstruction techniques (6 papers). Olaf Schultz is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (11 papers), Periodontal Regeneration and Treatments (8 papers) and Knee injuries and reconstruction techniques (6 papers). Olaf Schultz collaborates with scholars based in Germany, United States and Finland. Olaf Schultz's co-authors include Michael Sittinger, Carsten Perka, K Lindenhayn, Ron‐Sascha Spitzer, Gerd R Burmester, G.-R. Burmester, Thomas Häupl, Moritz Hahn, Matthias Laudes and Andrea Rubbert‐Roth and has published in prestigious journals such as PLoS ONE, Biomaterials and Clinical Orthopaedics and Related Research.

In The Last Decade

Olaf Schultz

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Schultz Germany 16 481 434 334 280 263 25 1.1k
Bernd Kinner Germany 15 583 1.2× 294 0.7× 239 0.7× 188 0.7× 180 0.7× 39 1.2k
Adel Alhadlaq Saudi Arabia 15 425 0.9× 259 0.6× 303 0.9× 571 2.0× 258 1.0× 28 1.3k
Gregory G. Reinholz United States 15 313 0.7× 408 0.9× 208 0.6× 175 0.6× 206 0.8× 19 1.0k
Benjamin A. Byers United States 12 341 0.7× 571 1.3× 332 1.0× 224 0.8× 176 0.7× 14 1.1k
Oliver B. Betz Germany 21 713 1.5× 317 0.7× 393 1.2× 358 1.3× 211 0.8× 46 1.5k
Marcus Mumme Switzerland 16 425 0.9× 570 1.3× 222 0.7× 236 0.8× 243 0.9× 30 1.0k
Henk‐Jan Prins Netherlands 20 394 0.8× 210 0.5× 400 1.2× 634 2.3× 312 1.2× 34 1.5k
Wouter J.F.M. Jurgens Netherlands 10 495 1.0× 189 0.4× 184 0.6× 658 2.4× 205 0.8× 12 1.0k
Ran Xiao China 21 323 0.7× 221 0.5× 203 0.6× 253 0.9× 209 0.8× 57 1.2k
Ling Wu China 23 396 0.8× 522 1.2× 213 0.6× 678 2.4× 294 1.1× 35 1.4k

Countries citing papers authored by Olaf Schultz

Since Specialization
Citations

This map shows the geographic impact of Olaf Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Schultz more than expected).

Fields of papers citing papers by Olaf Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Schultz. The network helps show where Olaf Schultz may publish in the future.

Co-authorship network of co-authors of Olaf Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Schultz. A scholar is included among the top collaborators of Olaf Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Schultz. Olaf Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultz, Olaf, et al.. (2024). Real-world experience with filgotinib for rheumatoid arthritis in Germany. Zeitschrift für Rheumatologie. 84(1). 39–47. 1 indexed citations
2.
Keyßer, Gernot, et al.. (2024). Welches Potential hat ChatGPT 3.5 für eine qualifizierte Patienteninformation?. Zeitschrift für Rheumatologie. 84(3). 179–187. 1 indexed citations
3.
Keyßer, Gernot, Andreas Michalsen, Monika Reuß‐Borst, et al.. (2023). Empfehlungen der Kommission Komplementäre Heilverfahren und Ernährung zu ayurvedischer Medizin, Homöopathie, Ernährung und mediterraner Kost. Zeitschrift für Rheumatologie. 82(6). 517–531. 4 indexed citations
4.
Schultz, Olaf, F. Oberhäuser, Andrea Rubbert‐Roth, et al.. (2010). Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases. PLoS ONE. 5(12). e14328–e14328. 173 indexed citations
5.
Schultz, Olaf, Ralph I. Rückert, G.-R. Burmester, & Frank Buttgereit. (2005). Akuter Mesenterialinfarkt bei Polychondritis. Zeitschrift für Rheumatologie. 65(1). 63–68. 2 indexed citations
6.
Schultz, Olaf, et al.. (2003). Case Number 26: Systemic idiopathic fibrosis associated with aortitis. Annals of the Rheumatic Diseases. 62(5). 486–486. 2 indexed citations
7.
Ringe, Jochen, Christian Kaps, Bernhard M. Schmitt, et al.. (2002). Porcine mesenchymal stem cells. Cell and Tissue Research. 307(3). 321–327. 179 indexed citations
8.
Ringe, Jochen, Christian Kaps, Bernhard M. Schmitt, et al.. (2002). PORCINE MESENCHYMAL STEM CELLS. INDUCTIONOF DISTINCT MESENCHYMAL CELL LINEAGES. 307(3). 321–327. 10 indexed citations
9.
Perka, Carsten, Ron‐Sascha Spitzer, K Lindenhayn, Michael Sittinger, & Olaf Schultz. (2000). Matrix-mixed culture: New methodology for chondrocyte culture and preparation of cartilage transplants. Journal of Biomedical Materials Research. 49(3). 305–311. 110 indexed citations
10.
Perka, Carsten, Olaf Schultz, Ron‐Sascha Spitzer, et al.. (2000). Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials. 21(11). 1145–1153. 186 indexed citations
11.
Perka, Carsten, et al.. (2000). Tissue Engineered Cartilage Repair Using Cryopreserved and Noncryopreserved Chondrocytes. Clinical Orthopaedics and Related Research. 378(378). 245–254. 33 indexed citations
12.
Stern, Scott J., K Lindenhayn, Olaf Schultz, & Carsten Perka. (2000). Cultivation of porcine cells from the nucleus pulposus in a fibrin/hyaluronic acid matrix. Acta Orthopaedica Scandinavica. 71(5). 496–502. 45 indexed citations
13.
Schultz, Olaf, et al.. (2000). Emerging strategies of bone and joint repair.. Arthritis Research. 2(6). 433–433. 20 indexed citations
14.
Perka, Carsten, Olaf Schultz, Ron‐Sascha Spitzer, & K Lindenhayn. (2000). The influence of transforming growth factor ?1 on mesenchymal cell repair of full-thickness cartilage defects. Journal of Biomedical Materials Research. 52(3). 543–552. 38 indexed citations
15.
Perka, Carsten, Olaf Schultz, Michael Sittinger, & H Zippel. (2000). Chondrocyte transplantation using PGLA/Polydioxanon fleeces. Der Orthopäde. 29(2). 112–119. 17 indexed citations
16.
Perka, Carsten, et al.. (1999). Bone engineering on the basis of periosteal cells cultured in polymer fleeces. Journal of Materials Science Materials in Medicine. 10(12). 767–772. 40 indexed citations
17.
Sittinger, Michael, Carsten Perka, Olaf Schultz, Thomas Häupl, & G.-R. Burmester. (1999). Joint cartilage regeneration by tissue engineering. Zeitschrift für Rheumatologie. 58(3). 130–135. 55 indexed citations
18.
Sittinger, Michael, Olaf Schultz, Gernot Keyszer, Will W. Minuth, & Gerd R Burmester. (1997). Artificial Tissues in Perfusion Culture. The International Journal of Artificial Organs. 20(1). 57–62. 78 indexed citations
19.
Schultz, Olaf, Gernot Keyszer, J. Zacher, Michael Sittinger, & Gerd R Burmester. (1997). Development of in vitro model systems for destructive joint diseases. Novel strategies for establishing inflammatory pannus. Arthritis & Rheumatism. 40(8). 1420–1428. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026